Cargando…
Rituximab Use for the Treatment of Childhood Nephrotic Syndrome by Canadian Pediatric Nephrologists: A National Survey
BACKGROUND: There is known practice variation in the treatment of frequently relapsing, steroid-dependent, and steroid-resistant nephrotic syndrome in children. Rituximab is an emerging therapy for difficult-to-treat nephrotic syndrome; however, there are no clear treatment guidelines. We therefore...
Autores principales: | Meeuwisse, Cory, Morgan, Catherine J., Samuel, Susan, Alexander, R Todd, Rodriguez-Lopez, Sara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922210/ https://www.ncbi.nlm.nih.gov/pubmed/35300066 http://dx.doi.org/10.1177/20543581221079959 |
Ejemplares similares
-
Knowledge and Practice of Incremental Hemodialysis: A Survey of Canadian Nephrologists
por: Dahiya, Anita, et al.
Publicado: (2021) -
The Diagnostic Journey of Childhood Idiopathic Nephrotic Syndrome: Perspectives of Children and Their Caregivers
por: Okpere, Augustina, et al.
Publicado: (2022) -
Strategies for improving primary care for adolescents and young adults transitioning from pediatric services: perspectives of Canadian primary health care professionals
por: Schraeder, Kyleigh, et al.
Publicado: (2020) -
Rituximab Use in the Management of Childhood Nephrotic Syndrome
por: Kallash, Mahmoud, et al.
Publicado: (2019) -
Optimising transitions of care for acute kidney injury survivors: protocol for a mixed-methods study of nephrologist and primary care provider recommendations
por: May, Heather Personett, et al.
Publicado: (2022)